Risk factors for community-acquired pneumonia among adults in Kenya: a case–control study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Scott JA, Hall AJ, Muyodi C, Lowe B, Ross M, Chohan B, et al. Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet. 2000;355(9211):1225–30.
Yone EW, Balkissou AD, Kengne AP, Kuaban C. Influence of HIV infection on the clinical presentation and outcome of adults with acute community-acquired pneumonia in Yaounde, Cameroon: a retrospective hospital-based study. BMC Pulm Med. 2012;12:46.
Sow O, Frechet M, Diallo AA, Soumah S, Conde MK, Diot P, et al. Community acquired pneumonia in adults: a study comparing clinical features and outcome in Africa (Republic of Guinea) and Europe (France). Thorax. 1996;51(4):385–8.
Farr BM, Bartlett CL, Wadsworth J, Miller DL. Risk factors for community-acquired pneumonia diagnosed upon hospital admission. British Thoracic Society pneumonia study group. Respir Med. 2000;94(10):954–63.
Torres A, Peetermans WE, Viegi G, Blasi F. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax. 2013;68(11):1057–65.
Baik I, Curhan GC, Rimm EB, Bendich A, Willett WC, Fawzi WWA. Prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med. 2000;160(20):3082–8.
Almirall J, Bolibar I, Balanzo X, Gonzalez CA. Risk factors for community-acquired pneumonia in adults: a population-based case–control study. Eur Respir J. 1999;13(2):349–55.
Koivula I, Sten M, Makela PH. Risk factors for pneumonia in the elderly. Am J Med. 1994;96(4):313–20.
Farr BM, Woodhead MA, Macfarlane JT, Bartlett CL, McCraken JS, Wadsworth J, et al. Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community. Respir Med. 2000;94(5):422–7.
Mannino DM, Davis KJ, Kiri VA. Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort. Respir Med. 2009;103(2):224–9.
Rose RM, Pinkston P, O'Donnell C, Jensen WA. Viral infection of the lower respiratory tract. Clin Chest Med. 1987;8(3):405–18.
Bosch AA, Biesbroek G, Trzcinski K, Sanders EA, Bogaert D. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog. 2013;9(1):e1003057.
Weinberger DM, Klugman KP, Steiner CA, Simonsen L, Viboud C. Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data. PLoS Med. 2015;12(1):e1001776.
Aston SJ, Rylance J. Community-acquired pneumonia in sub-Saharan Africa. Semin Respir Crit Care Med. 2016;37(6):855–67.
Penner J, Meier AS, Mwachari C, Ayuka F, Muchina B, Odhiambo J, et al. Risk factors for pneumonia in urban-dwelling HIV-infected women: a case–control study in Nairobi, Kenya. J Acquir Immune Defic Syndr. 2003;32(2):223–8.
Chen Y, Li W, Influence YS. Of passive smoking on admissions for respiratory illness in early childhood. Br Med J (Clin Res Ed). 1986;293(6542):303–6.
Fergusson DM, Horwood LJ, Shannon FT, Taylor B. Parental smoking and lower respiratory illness in the first three years of life. J Epidemiol Community Health. 1981;35(3):180–4.
Strachan DP, Cook DG. Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax. 1997;52(10):905–1.
Odenwald M, Neuner F, Schauer M, Elbert T, Catani C, Lingenfelder B, et al. Khat use as risk factor for psychotic disorders: a cross-sectional and case–control study in Somalia. BMC Med. 2005;3:5.
Patel NB. "Natural amphetamine" Khat: a cultural tradition or a drug of abuse. Int Rev Neurobiol. 2015;120:235–55.
Pantelis C, Hindler CG, Taylor JC. Use and abuse of khat (Catha Edulis): a review of the distribution, pharmacology, side effects and a description of psychosis attributed to khat chewing. Psychol Med. 1989;19(3):657–68.
Grijalva CG, Zhu Y, Williams DJ, Self WH, Ampofo K, Pavia AT, et al. Association between hospitalization with community-acquired laboratory-confirmed influenza pneumonia and prior receipt of influenza vaccination. JAMA. 2015;314(14):1488–97.
Ferdinands JM, Gargiullo P, Haber M, Moore M, Belongia EA, Shay DK. Inactivated influenza vaccines for prevention of community-acquired pneumonia: the limits of using nonspecific outcomes in vaccine effectiveness studies. Epidemiology. 2013;24(4):530–7.
Jackson ML, Nelson JC, Weiss NS, Neuzil KM, Barlow W, Jackson LA. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case–control study. Lancet. 2008;372(9636):398–405.
Talbot HK, Zhu Y, Chen Q, Williams JV, Thompson MG, Griffin MR. Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in adults, 2011–2012 influenza season. Clin Infect Dis. 2013;56(12):1774–7.
Johnston IDA, Strachan DP, Anderson HR. Effect of pneumonia and whooping cough in childhood on adult lung function. N Engl J Med. 1998;338(9):581–7.
Grimwood K, Chang AB. Long-term effects of pneumonia in young children. Pneumonia. 2015;6(1):101–14.
Munywoki PK, Ohuma EO, Ngama M, Bauni E, Scott JAG, Nokes DJ. Severe lower respiratory tract infection in early infancy and pneumonia hospitalizations among children, Kenya. Emerg Infect Dis. 2013;19(2):223–9.
Hedlund JU, Kalin ME, Ortqvist AB, Henrichsen J. Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia. Arch Intern Med. 1994;154(17):1961–5.
Gordon SB, Bruce NG, Grigg J, Hibberd PL, Kurmi OP, Lam KB, et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med. 2014;2(10):823–60.
Ezzati M, Kammen D. Indoor air pollution from biomass combustion and acute respiratory infections in Kenya: an exposure-response study. Lancet. 2001;358(9282):619–24.
Smith KR, Samet JM, Romieu I, Bruce N. Indoor air pollution in developing countries and acute lower respiratory infections in children. Thorax. 2000;55(6):518–32.
Dherani M, Pope D, Mascarenhas M, Smith KR, Weber M, Bruce N. Indoor air pollution from unprocessed solid fuel use and pneumonia risk in children aged under five years: a systematic review and meta-analysis. Bull World Health Organ. 2008;86(5):390–8c.
Jary H, Simpson H, Havens D, Manda G, Pope D, Bruce N, et al. Household air pollution and acute lower respiratory infections in adults: a systematic review. PLoS One. 2016;11(12):e0167656.
Jary H, Mallewa J, Nyirenda M, Faragher B, Heyderman R, Peterson I, et al. Study protocol: the effects of AIR pollution exposure and chronic respiratory disease on pneumonia risk in urban Malawian adults--the acute infection of the respiratory tract study (the AIR study). BMC Pulm Med. 2015;15:96.
Vinogradova Y, Coupland C, Hippisley-Cox J. Risk of pneumonia in patients taking statins: population-based nested case–control study. Br J Gen Pract. 2011;61(592):e742–8.
Vinogradova Y, Hippisley-Cox J, Coupland C. Identification of new risk factors for pneumonia: population-based case–control study. Br J Gen Pract. 2009;59(567):e329–38.
Okeyo TMBG, Stover J. Johnston a,. AIDS in Kenya: background, projections, impact, and interventions. Nairobi. Kenya: National AIDS and STDs Control Programme (NASCOP; 1998.
Flanagan KL, Plebanski M. Sex-differential heterologous (non-specific) effects of vaccines: an emerging public health issue that needs to be understood and exploited. Expert review Vaccine. 2017;16(1):5–13.
Aaby P, Kollmann TR, Benn CS. Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges. Nature Immunology. 2014;15(1529–2916 (Electronic)).
Roth A, Sodemann M, Jensen H, Poulsen A, Gustafson P, Weise C, et al. Tuberculin reaction, BCG scar, and lower female mortality. Epidemiology. 2006;17(5):562–8.
Aaby P, Gustafson P, Roth A, Rodrigues A, Fernandes M, Sodemann M, et al. Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau. Vaccine. 2006;24(29–30):5718–25.
Meeting of the Strategic Advisory Group of Experts on immunization, April 2014 -- conclusions and recommendations. Wkly Epidemiol Rec. 2014;89(21):221–36.
Grubb JR, Moorman AC, Baker RK, Masur H. The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy. AIDS. 2006;20(8):1095–107.